drugset / Trial / NCT00914186

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

NCT00914186 ↗

Phase 2 Completed 122 enrolled Taisho Pharmaceutical R&D Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose and (primary) objectives of this study are to evaluate the efficacy, safety, and tolerability of TS-022 in adults with atopic dermatitis who have moderate to very severe pruritus (itching), following a 28-day regimen of twice-daily topical application.

Timeline

Start
2009-06
Primary completion
2010-05
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject TS-022 Unknown 0.005 % Topical
Subject TS-022 Unknown 0.01 % Topical
Subject TS-022 Unknown 0.02 % Topical

Indications